Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
April 01, 2015
JTCB. 2015 Apr 1; 13 (1) : 015-020

Levels of Ferritin, Vitamin B12 and Folic Acid in Patients with Vitiligo in Usak Region

1 Uşak Devlet Hastanesi, Tıbbi Biyokimya, Uşak, Türkiye
2 Fırat Üniversitesi, Tıp Fakültesi, Tıbbi Biyoloji, Elazığ, Türkiye
3 Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbi Biyokimya, İstanbul, Türkiye
4 Erciyes üniversitesi, Mühendislik Fakültesi, Bilgisayar Mühendisliği, Kayseri, Türkiye

Abstract

Objective: Vitiligo is an acquired depigmentation disorder occur with destruction of melanocytes, a common skin disease. We aimed to investigate ferritin, vitamin B12 and folic acid levels in patients with vitiligo in Usak region.

Material and Methods: A hundred and two cases with vitiligo (60 female and 42 male) and a hundred and two control subjects (60 female and 42 male) were enrolled in this study. Ferritin, vitamin B12 and folic levels were measured by Advia Centaur XP (Siemens, USA). The collected data were analyzed by SPSS version11.5.

Results: Comparing the patients and control subjects, the mean values of ferritin were found a statistically significant difference between groups (p = 0.664). The mean values of vitamin B12 and folic acid have detected statistically significant difference between groups (p = 0.041 and p = 0.025, respectively).

Conclusion: Vitamin B12 and folic acid may play a role in the pathogenesis of vitiligo disease. We recommend that vitamin B12 and folic acid deficiency in patients with vitiligo were evaluated in the outpatient clinical examination and laboratory tests are done periodically in follow-up.

Citation

Etem, Arzu Akağaç, Ebru Önalan Etem, Sembol Türkmen Yıldırmak, and Mehmet Kırtay. 2015. “Levels of Ferritin, Vitamin B12 and Folic Acid in Patients With Vitiligo in Usak Region”. Journal of Turkish Clinical Biochemistry 13 (1):015-020. https://turkclinbiochem.org/index.php/pub/article/view/215.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.